ATC Group: N01BB01 Bupivacaine

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of N01BB01 in the ATC hierarchy

Level Code Title
1 N Nervous system
2 N01 Anesthetics
3 N01B Anesthetics, local
4 N01BB Amides
5 N01BB01 Bupivacaine

Active ingredients in N01BB01

Active Ingredient Description
Bupivacaine

Bupivacaine is an amide-type, long-acting local anesthetic. Bupivicaine reversibly binds to specific sodium ion channels in the neuronal membrane, resulting in a decrease in the voltage-dependent membrane permeability to sodium ions and membrane stabilization; inhibition of depolarization and nerve impulse conduction; and a reversible loss of sensation.

Related product monographs

Title Information Source Document Type  
BUPICAN Solution for injection Health Products Regulatory Authority (ZA) MPI, Generic
EXPAREL Suspension for solution for injection FDA, National Drug Code (US) MPI, US: SPL/PLR
MARCAIN HEAVY Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MARCAIN POLYAMP STERIPACK Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MARCAINE Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
SENSORCAINE Solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old

Medicines in this ATC group

United States (US)

Austria (AT)

Brazil (BR)

Canada (CA)

Croatia (HR)

Ecuador (EC)

Hong Kong (HK)

Ireland (IE)

Israel (IL)

Japan (JP)

Malta (MT)

Netherlands (NL)

New Zealand (NZ)

Poland (PL)

Singapore (SG)

South Africa (ZA)

Tunisia (TN)

United Kingdom (UK)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.